Pancreatic Cancer Research

Journal articleCancer Chemother Pharmacol2015

Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer.

Journal
Cancer Chemother Pharmacol
Published
11 November 2015
Citations
16
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Purpose We conducted a retrospective cohort study to examine whether neutropenia could be an indicator of good prognosis in patients treated with gemcitabine (GEM) for unresectable pancreatic cancer. Methods A total of 178 patients with unresectable pancreatic cancer, who were treated with first-line (n = 121) or second-line (n = 57) GEM, were included in our analyses. … Excerpt only: this text is the publisher’s. Read it in full at the source.